Enzon Pharmaceuticals (ENZN) Earnings Date, Estimates & Call Transcripts → One trade. One ticker. One week. (From Wealthpin Pro) (Ad) Free ENZN Stock Alerts $0.08 0.00 (0.00%) (As of 04/24/2024 ET) Add Compare Share Share EarningsStock AnalysisChartEarningsFinancialsSEC FilingsShort InterestStock AnalysisChartEarningsFinancialsSEC FilingsShort Interest Earnings SummaryLatest Earnings DateMar. 20EstimatedActual EPS (Mar. 20) $0.01 Beat By $0.01 Get Enzon Pharmaceuticals Earnings AlertsEnter your email address below to receive the latest news and earnings results for ENZN and its competitors with MarketBeat's FREE daily newsletter. Skip Charts & View Estimated and Actual Earnings DataEarnings Per ShareRevenueENZN Earnings Estimates and Actuals by QuarterEarnings Estimates and Acutals by Quarter Chart DescriptionThe chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.ENZN Estimated and Actual Revenue by Quarter Estimated Revenue and Actual Revenue by Quarter Chart DescriptionThe chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter. Ad TradeSmithThe A.I. story nobody is telling you (Read ASAP)There's been a lot of buzz surrounding A.I. over the past year... Most of it is just hype and speculation. But there's one recent A.I. development you NEED to hear about...Click here to see Louis' new video for yourself. ENZN Earnings Date and InformationEnzon Pharmaceuticals last announced its quarterly earnings results on March 20th, 2024. The biotechnology company reported $0.01 EPS for the quarter. Enzon Pharmaceuticals has generated $0.01 earnings per share over the last year ($0.01 diluted earnings per share) and currently has a price-to-earnings ratio of 7.8. Read More Enzon Pharmaceuticals Earnings History by Quarter Custom Range 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years 5 Years Time Frame * Start Date * End Date Export to Excel DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueCall Transcript3/20/2024Q4 2023-$0.01+$0.01$0.01--2/16/2023Q4 2022-$0.01+$0.01$0.01-$0.03 million11/9/2022Q3 2022-($0.01)($0.01)($0.01)--8/4/2022Q2 2022-($0.01)($0.01)($0.01)--4/26/2022Q1 2022-($0.01)($0.01)($0.01)--2/25/2022Q4 2021-($0.01)($0.01)($0.01)-$0.03 million Get the Latest News and Ratings for ENZN and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Enzon Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. 11/5/2021Q3 2021-($0.01)($0.01)($0.01)--8/5/2021Q2 2021-($0.01)($0.01)($0.01)-$0.29 million5/4/2021Q1 2021-($0.01)($0.01)($0.01)-$0.38 million Enzon Pharmaceuticals Earnings - Frequently Asked Questions When did Enzon Pharmaceuticals announce their last quarterly earnings? Enzon Pharmaceuticals (OTCMKTS:ENZN) last announced its quarterly earning data on Wednesday, March 20, 2024. Learn more on ENZN's earnings history. How much revenue does Enzon Pharmaceuticals generate each year? Enzon Pharmaceuticals (OTCMKTS:ENZN) has a recorded annual revenue of $30,000.00. How much profit does Enzon Pharmaceuticals generate each year? Enzon Pharmaceuticals (OTCMKTS:ENZN) has a recorded net income of $1.37 million. ENZN has generated $0.01 earnings per share over the last four quarters. What is Enzon Pharmaceuticals's price-to-earnings ratio? Enzon Pharmaceuticals (OTCMKTS:ENZN) has a trailing price-to-earnings ratio of 7.80. More Earnings Resources from MarketBeat Related Companies: ALVO Earnings Results Earnings Tools: Today's Earnings Tomorrow's Earnings Next Week's Earnings Upcoming Earnings Calls Earnings Newsletter Earnings Call Transcripts Earnings Beats & Misses Corporate Guidance Earnings Screener Earnings By Country: U.S. Earnings Reports Canadian Earnings Reports U.K. Earnings Reports Australia Earnings Reports Latest Articles: GE Aerospace is Ready for Liftoff After Strong EarningsTaiwan Semiconductor Earnings: AI Dominance and Future OutlookCSX Co.: The Railroad Powering Ahead with an Earnings Beat What's Driving Tesla Lower Ahead of its Earnings?Blackrock vs. State Street: Earnings in a Volatile MarketWhat to Expect From the Q1 Earnings Reporting SeasonLululemon Stock Implodes Post Earnings, Guidance Muted This page (OTCMKTS:ENZN) was last updated on 4/24/2024 by MarketBeat.com Staff From Our Partnerstop AI stock (it’s not MSFT, GOOGL, AMZN or AAPL)Traders AgencyExposed: 10 CENT Crypto to Explode April 20th?True Market InsidersThe #1 Biotech Stock to Have on Your Radar in 2024… Huge AlertsFed launches fourth dollar overhaulStansberry ResearchMan Who Predicted 2008: “This Will be Worse.”Altimetry Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Enzon Pharmaceuticals, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
